Back to Search
Start Over
Development of an NGS assay to detect MRD in hematologic malignancies
- Source :
- Journal of Clinical Oncology. 36:e24177-e24177
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- e24177Background: There are significant prognostic and therapeutic benefits in monitoring minimal/measurable residual disease (MRD) in hematologic malignancies. However, monitoring of MRD requires ...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........97020bbcbc017579c1d8e595ae174ed4
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.e24177